Neuronal Ceroid Lipofuscinosis 7 C1838571
NCL7 is a rare inherited condition where cellular waste products accumulate, causing progressive damage to the brain and nervous system. Children usually develop normally before symptoms appear, then experience seizures, vision loss, and motor decline. Management involves supportive treatments.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- fatal
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Early-onset severe vision loss
Generalized symptoms
Progressive symptoms that can become life-threatening without treatment.
Seek immediate medical attention if symptoms worsen.
Refractory seizures
Progressive motor decline with loss of milestones
(neurologic)Speech and language deterioration
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anticonvulsant management
Anticonvulsant medications form the cornerstone of symptom management for neuronal ceroid lipofuscinosis 7, controlling the seizures that typically emerge during the disease course. Medication regimens often require periodic review and modification.
Percutaneous intervention with follow-up
Treatment may require specialized care, hospitalization, or long-term management under medical supervision.
Progressive mobility therapy
Occupational and physical therapy interventions help maintain functional abilities as motor deterioration progresses. Therapists focus on adaptive techniques, assistive devices, and strategies to maximize independence in daily activities.
Additional treatment options
Gastrostomy tube placement
Surgical placement of a feeding tube becomes necessary when oral intake becomes unsafe or insufficient due to progressive swallowing difficulties. This procedure ensures adequate nutrition and hydration while preventing aspiration.
surgicalMultimodal supportive care
Complementary approaches including massage therapy, music therapy, and sensory stimulation may provide comfort and improve quality of life. These therapies can help manage anxiety and provide meaningful engagement.
complementaryMultidisciplinary progression tracking
Regular assessments by neurology, ophthalmology, and developmental specialists track disease progression and allow for proactive management of emerging symptoms and complications.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Neuronal Ceroid Lipofuscinosis 7 C1838571?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Williams RE, Adams HR, Blohm M, et al. Management Strategies for CLN2 Disease. J Inherit Metab Dis. 2017.
Mole SE, Cotman SL. Genetics of the Neuronal Ceroid Lipofuscinoses. Biochim Biophys Acta. 2015.
Kohan R, Pesa S, Dodelson de Kremer R. MFSD8 Gene Mutations in Latin American Patients with Neuronal Ceroid Lipofuscinosis. Mol Genet Metab. 2020.
Nita DA, Mole SE, MINC Consortium. The Neuronal Ceroid Lipofuscinoses: Standards of Care. Neurology. 2016.
Medication Comparisons
Compare medications used to treat Neuronal Ceroid Lipofuscinosis 7 C1838571. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy